Stem cell transplants may slow disability progression in MS
22 Dec 2022 //
EUROPEANPHARMACEUTICALREVIEW
Teva`s troubled plant seen to create injectable drug shortages
24 May 2022 //
FIERCEPHARMA
Actinium Shows 72% MRD Negativity Rate in Phase 1 Study of Actimab-A + CLAG-M
14 Dec 2021 //
PRNEWSWIRE